References
- Kordas K, Ravenscroft J, Cao Y, McLean EV. Lead exposure in low and middle-income countries: perspectives and lessons on patterns, injustices, economics, and politics. IJERPH. 2018;15(11):2351. doi:https://doi.org/10.3390/ijerph15112351.
- Staudinger KC, Roth VS. Occupational lead poisoning. Am Fam Physician. 1998;57(719–726):731–712.
- Agency for Toxic Substances and Disease Registry, AGUDoHoHS, Public Health Service. The priority of hazardous substances. 2011. https://www.atsdr.cdc.gov/spl/index.html
- Mason LH, Harp JP, Han DY. Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed Res Int. 2014;2014:840547. doi:https://doi.org/10.1155/2014/840547.
- Nawrot TS, Thijs L, Den Hond EM, et al. An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens. 2002;16(2):123–131. doi:https://doi.org/10.1038/sj.jhh.1001300.
- Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med. 2002;162(21):2443–2449. doi:https://doi.org/10.1001/archinte.162.21.2443.
- Schober SE, Mirel LB, Graubard BI, et al. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect. 2006;114(10):1538–1541. doi:https://doi.org/10.1289/ehp.9123.
- Gracia RC, Snodgrass WR. Lead toxicity and chelation therapy. Am J Health Syst Pharm. 2007;64(1):45–53. doi:https://doi.org/10.2146/ajhp060175.
- Peguero JG, Arenas I, Lamas GA. Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients. Trends Cardiovasc Med. 2014;24(6):232–240. doi:https://doi.org/10.1016/j.tcm.2014.06.002.
- Karakulak UN, Yilmaz OH, Tutkun E, et al. Comprehensive electrocardiographic analysis of lead exposed workers: an arrhythmic risk assessment study. Ann Noninvasive Electrocardiol. 2017;22(2):e12376. doi:https://doi.org/10.1111/anec.12376.
- Poreba R, Poreba M, Gac P, et al. Electrocardiographic changes in workers occupationally exposed to lead. Ann Noninvasive Electrocardiol. 2011;16:33–40.
- Barry PS, Mossman DB. Lead concentrations in human tissues. Br J Ind Med. 1970;27(4):339–351. doi:https://doi.org/10.1136/oem.27.4.339.
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:https://doi.org/10.1093/eurheartj/ehy339.
- Magnani JW, Mazzini MJ, Sullivan LM, et al. P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol. 2010;15(1):77–84. doi:https://doi.org/10.1111/j.1542-474X.2009.00343.x.
- Pérez-Riera AR, de Abreu LC, Barbosa-Barros R, et al. P-wave dispersion: an update. Indian Pacing Electrophysiol J. 2016;16(4):126–133. doi:https://doi.org/10.1016/j.ipej.2016.10.002.
- Bazett H. An analysis of the time‐relations of electrocardiograms. Ann Noninvasive Electrocardiol. 1997;2(2):177–194. doi:https://doi.org/10.1111/j.1542-474X.1997.tb00325.x.
- Rosenthal TM, Masvidal D, Abi Samra FM, et al. Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention. EP Europace. 2018;20(4):698–705. doi:https://doi.org/10.1093/europace/euw430.
- Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64. doi:https://doi.org/10.1016/j.echo.2018.06.004.
- Kumar S, Jain S, Aggarwal CS, Ahuja GK. Encephalopathy due to inorganic lead exposure in an adult. Jpn J Med. 1987;26(2):253–254. doi:https://doi.org/10.2169/internalmedicine1962.26.253.
- Koller K, Brown T, Spurgeon A, Levy L. Recent developments in low-level lead exposure and intellectual impairment in children. Environ Health Perspect. 2004;112(9):987–994. doi:https://doi.org/10.1289/ehp.6941.
- Hwang L. Environmental stressors and violence: lead and polychlorinated biphenyls. Rev Environ Health. 2007;22(4):313–328. doi:https://doi.org/10.1515/reveh.2007.22.4.313.
- Janin Y, Couinaud C, Stone A, Wise L. The "lead-induced colic" syndrome in lead intoxication. Surg Annu. 1985;17:287–307.
- Rastogi SK. Renal effects of environmental and occupational lead exposure. Indian J Occup Environ Med. 2008;12(3):103–106. doi:https://doi.org/10.4103/0019-5278.44689.
- Hirschfeld E. Angina pectoris saturnina. Z Klin Med. 1926;104:698–712
- Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect. 1991;91:71–75. doi:https://doi.org/10.1289/ehp.919171.
- Pocock SJ, Shaper AG, Ashby D, et al. The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ Health Perspect. 1988;78:23–30. doi:https://doi.org/10.1289/ehp.887823.
- Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18(2):321–336. doi:https://doi.org/10.1016/0891-5849(94)00159-H.
- Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease–a systematic review. Environ Health Perspect. 2007;115(3):472–482. doi:https://doi.org/10.1289/ehp.9785.
- Kristal-Boneh E, Coller D, Froom P, et al. The association between occupational lead exposure and serum cholesterol and lipoprotein levels. Am J Public Health. 1999;89(7):1083–1087. doi:https://doi.org/10.2105/ajph.89.7.1083.
- Chen CC, Yen HW, Lo YH, et al. The association of prolonged QT interval on electrocardiography and chronic lead exposure. J Occup Environ Med. 2013;55(6):614–619. doi:https://doi.org/10.1097/JOM.0b013e318291787a.
- Cheng Y, Schwartz J, Vokonas PS, et al. Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study). Am J Cardiol. 1998;82(5):594–599. doi:https://doi.org/10.1016/S0002-9149(98)00402-0.
- Jing J, Thapa S, Delhey L, et al. The relation of blood lead and QRS-T angle in American adults. Arch Environ Occup Health. 2019;74(5):287–291. doi:https://doi.org/10.1080/19338244.2018.1488674.
- Spach MS, Miller WT, Geselowitz DB, et al. The discontinuous nature of propagation in normal canine cardiac muscle. Evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents. Circ Res. 1981;48(1):39–54. doi:https://doi.org/10.1161/01.res.48.1.39.
- Saffitz JE, Kanter HL, Green KG, et al. Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res. 1994;74(6):1065–1070. doi:https://doi.org/10.1161/01.RES.74.6.1065.
- Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135(5 Pt 1):733–738. doi:https://doi.org/10.1016/S0002-8703(98)70030-4.
- Barr CS, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994;343(8893):327–329. doi:https://doi.org/10.1016/S0140-6736(94)91164-9.
- Pye M, Quinn AC, Cobbe SM. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J. 1994;71(6):511–514. doi:https://doi.org/10.1136/hrt.71.6.511.
- Ferreira de Mattos G, Costa C, Savio F, et al. Lead poisoning: acute exposure of the heart to lead ions promotes changes in cardiac function and Cav1.2 ion channels. Biophys Rev. 2017;9(5):807–825. doi:https://doi.org/10.1007/s12551-017-0303-5.
- Bertel O, Bühler FR, Ott J. Lead-induced hypertension: blunted beta-adrenoceptor-mediated functions. Br Med J. 1978;1(6112):551–551. doi:https://doi.org/10.1136/bmj.1.6112.551.
- Kopp SJ, Barron JT, Tow JP. Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect. 1988;78:91–99. doi:https://doi.org/10.1289/ehp.887891.
- Gajek J, Zyśko D, Chlebda E. Heart rate variability in workers chronically exposed to lead. Kardiol Pol. 2004;61:21–30.
- Dey S, Swarup D, Singh GR. Effect of experimental lead toxicity on cardiovascular function in calves. Vet Hum Toxicol. 1993;35(6):501–503.
- Kline TS. Myocardial changes in lead poisoning. AMA J Dis Child. 1960;99:48–54. doi:https://doi.org/10.1001/archpedi.1960.02070030050009.
- Knudtson ML, Wyse DG, Galbraith PD, et al. Chelation therapy for ischemic heart disease: a randomized controlled trial. JAMA. 2002;287(4):481–486. doi:https://doi.org/10.1001/jama.287.4.481.
- Seely DMR, Wu P, Mills EJ. EDTA chelation therapy for cardiovascular disease: a systematic review. BMC Cardiovasc Disord. 2005;5:32–32. doi:https://doi.org/10.1186/1471-2261-5-32.
- Elihu N, Anandasbapathy S, Frishman WH. Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane. J Clin Pharmacol. 1998;38(2):101–105. doi:https://doi.org/10.1002/j.1552-4604.1998.tb04397.x.
- Kindness G, Frackelton J. Effect of ethylene diamine tetraacetic acid (EDTA) on platelet aggregation in human blood. J Adv Med. 1989;2:519–530
- Frishman WH. Chelation therapy for coronary artery disease: panacea or quackery? Am J Med. 2001;111(9):729–730. doi:https://doi.org/10.1016/s0002-9343(01)01056-7.